News

Filter

Current filters:

None

8101 to 8110 of 97252 results

Regulatory filing preparations underway for Vifor's PA21 on good Ph III results

09-07-2012

The pivotal Phase III clinical study shows that the new phosphate binder PA21 successfully controls hyperphosphatemia…

FreseniusGalenicaNephrology and HepatologyPA21PharmaceuticalRegulationResearchVifor Pharma

AstraZeneca completes sale of Aptium Oncology assets

09-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

Boehringer Ingelheim links with Harvard for unmet medical needs research

09-07-2012

Family-controlled German drug major Boehringer Ingelheim has established a translational research collaboration…

Antibiotics and Infectious diseasesBoehringer IngelheimOncologyPharmaceuticalResearch

European governments' austerity pricing tactics support generic drug growth

09-07-2012

Government initiatives to cut health expenditure are likely to encourage sales of generic medications…

BiotechnologyEuropeGenericsMarkets & MarketingPoliticsPricing

Horizon Discovery and Bayer collaborate on oncology programs

09-07-2012

UK-based Horizon Discovery, a provider of research tools to support the development of personalized medicines,…

OncologyPharmaceuticalResearch

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR

09-07-2012

US drug majors Eli Lilly (NYSE: LLY) and Bristol-Myers Squibb (NYSE: BMY) on Friday received full approval…

Bristol-Myers SquibbEli LillyErbituxNorth AmericaOncologyPharmaceuticalQiagenRegulation

Sucampo fails in Amitiza arbitration with Takeda

09-07-2012

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision…

AmitizaLegalLicensingPharmaceuticalResculaSucampoTakeda Pharmaceuticals

Novartis Indian Supreme Court hearings again re-scheduled

09-07-2012

Humanitarian aid agency Medecins Sans Frontieres said on Friday it has learnt that final arguments in…

Asia-PacificGenericsGleevecGlivecLegalNovartisPatentsPharmaceutical

Spectrum extends tender offer for Allos

09-07-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

8101 to 8110 of 97252 results

Back to top